Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

China · Delayed Price · Currency is CNY

43.97

-0.09 (-0.20%)

At close: Aug 24, 2026

19.26% (1Y)

Market Cap	4.76B +19.2%
Revenue (ttm)	448.33M +4.6%
Net Income	23.54M -62.0%
EPS	0.21 -62.9%
Shares Out	108.29M
PE Ratio	206.12
Forward PE	n/a
Dividend	0.05 (0.11%)
Ex-Dividend Date	Jun 16, 2026

Volume	2,077,818
Open	44.13
Previous Close	44.06
Day's Range	43.13 - 45.00
52-Week Range	25.87 - 59.24
Beta	0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About SHE:301281

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations. It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clarithromycin L-lactate; chlorpheniramine maleate; esmolol hydrochloride; isoproterenol hydrochloride; nicotinamide-tinidazole; aminolevulinate; nisoldipine; qupibutu; propafenone hydrochloride; potass... [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

Founded 2004

Employees 650

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301281

Full Company Profile

Financial Performance

In 2025, SHE:301281's revenue was 398.23 million, a decrease of -14.12% compared to the previous year's 463.72 million. Earnings were 16.55 million, a decrease of -72.62%.

Financial Statements